Strides Arcolab

Trending Articles

  1. Serialisation and data connectivity: Part I The new wrinkle in your supply chain
  2. Liquid versus lyophilised: overcoming the challenges of high-potency formulations in modern pharma Formulating highly potent (HiPo) compounds presents unique challenges that require expertise and precise decision making
  3. SGS’s Shanghai Health Science laboratory completes US FDA inspection with zero 483 observations SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an...
  4. Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche Acquisition extends Lonza’s US Biologics footprint with a significant presence on the West Coast, complementing its existing global manufacturing network
  5. SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Manufacturing

Indian Stride Pharma acquires FDA-approved US manufacturing facility

The facility will meet the enhanced capacity needs for soft gels and will offer an alternate site to Strides’ flagship facility in Bangalore
Finance

Strides Shasun acquires three OTC brands from Moberg Pharma

Indian firm is building an over-the-counter drug franchise in regulated and emerging markets
Finance

Sun Pharma to sell Ranbaxy's CNS divisions to Strides Arcolab

Deal is of strategic significance to growth of Strides branded business in India
Finance

Strides to buy drug assets in Australia and Mauritius from Aspen for approximately US$300m

Part of aim to focus on areas where most value can be added, says Strides
Manufacturing

Stelis Biopharma begins construction of US$60m multiproduct biologics facility in Malaysia

Will incorporate the latest single-use bioreactor systems for scale-up and process development

Vietnam bans companies making \'substandard\' drugs

Companies banned include 45 Indian pharmaceutical companies along with others from Korea, France and Pakistan
Finance

US regulators put conditions of Mylan Agila deal

Companies will have to divest 11 generic injectable drugs as a condition of approving the deal
Subscribe now